These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8682172

  • 1. 1,25-Dihydroxyvitamin D3 and transforming growth factor-beta act synergistically to override extinction of liver/bone/kidney alkaline phosphatase in osteosarcoma hybrid cells.
    Johnson-Pais TL, Leach RJ.
    Exp Cell Res; 1996 Jul 10; 226(1):67-74. PubMed ID: 8682172
    [Abstract] [Full Text] [Related]

  • 2. 1,25-Dihydroxyvitamin D3 and Transforming Growth Factor-beta Act Synergistically to Override Extinction of LiversolidusBonesolidusKidney Alkaline Phosphatase in Osteosarcoma Hybrid Cells.
    Johnson-Pais TL, Leach RJ.
    Exp Cell Res; 1996 Jul 10; 226(1):67-74. PubMed ID: 8660940
    [Abstract] [Full Text] [Related]

  • 3. Regulation of osteoblast gene expression in intratypic osteosarcoma hybrid cells.
    Johnson-Pais TL, Leach RJ.
    Exp Cell Res; 1995 Dec 10; 221(2):370-6. PubMed ID: 7493636
    [Abstract] [Full Text] [Related]

  • 4. Extinction of liver/bone/kidney alkaline phosphatase in osteosarcoma hybrid cells.
    Johnson-Pais TL, Leach RJ.
    Somat Cell Mol Genet; 1992 Sep 10; 18(5):423-30. PubMed ID: 1475709
    [Abstract] [Full Text] [Related]

  • 5. Effects of combining transforming growth factor beta and 1,25-dihydroxyvitamin D3 on differentiation of a human osteosarcoma (MG-63).
    Bonewald LF, Kester MB, Schwartz Z, Swain LD, Khare A, Johnson TL, Leach RJ, Boyan BD.
    J Biol Chem; 1992 May 05; 267(13):8943-9. PubMed ID: 1577731
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype.
    Varga F, Spitzer S, Klaushofer K.
    Calcif Tissue Int; 2004 Apr 05; 74(4):382-7. PubMed ID: 15255076
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
    Andrades JA, Han B, Becerra J, Sorgente N, Hall FL, Nimni ME.
    Exp Cell Res; 1999 Aug 01; 250(2):485-98. PubMed ID: 10413602
    [Abstract] [Full Text] [Related]

  • 19. Effects of orbital spaceflight on human osteoblastic cell physiology and gene expression.
    Harris SA, Zhang M, Kidder LS, Evans GL, Spelsberg TC, Turner RT.
    Bone; 2000 Apr 01; 26(4):325-31. PubMed ID: 10719274
    [Abstract] [Full Text] [Related]

  • 20. Effects of inhibitors of signal transduction pathways on transforming growth factor beta1 and osteogenic protein-1-induced insulinlike growth factor binding protein-3 expression in human bone cells.
    Srinivasan N, Baylink DJ, Sampath K, Mohan S.
    J Cell Physiol; 1997 Oct 01; 173(1):28-35. PubMed ID: 9326446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.